Adverse Event Clinical Research
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Artifacts Summary

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

Structures: Resource Profiles

These define constraints on FHIR resources for systems conforming to this implementation guide.

Adverse Event Clinical Research

Foundational profile of AdverseEvent for Clinical Research communications.

Structures: Extension Definitions

These define constraints on FHIR data types for systems conforming to this implementation guide.

Adverse Event Grade

For cancer related trials, severity is represented as a grade. Describes the grade of the adverse event, in relation to the subject not the resulting condition. In the context of clinical research, it is the investigator’s assessment of severity, in oncology related trials this is reported as grade.

Adverse Event Severity

Describes the severity of the adverse event, in relation to the subject not the resulting condition. In the context of clinical research, it is the investigator’s assessment of severity.

Adverse event caused subject to discontinue the study

Indicates if the subject discontinued the study due to the adverse event.

Criteria reviewed in determining serious adverse event

Element to capture the presence or absence of specific factors (criteria) associated with serious adverse events.

Example: Example Instances

These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.

AdverseEventFromProcedureNotStudyDrug

Adverse event from procedure, not study drug

ClinicalTrialSignificantAdverseEvent

example

NonSeriousAdverseEventResearchStudyMed

Non-Serious Adverse Event Research Study Medication Example

Patient reported AE during research study

Patient report of Adverse Event, example of data that would be on MedWatch form as reported by Patient

SeriousAdverseEventResearchStudy

Serious Adverse Event Research Study Medication Example

adverse-event-compass-ex1

Grade 1 ALT

adverse-event-compass-ex1a

Grade 3 ALT

adverse-event-compass-ex1b

ALT back to grade 1 and resolved

adverse-event-compass-ex2

Grade 1 Nausea/vomiting // both are AEs, which to use or make them separate?

adverse-event-device-death

Device suspected entity

Other

These are resources that are used within this implementation guide that do not fit into one of the other categories.

AEHeadache

Headache

AEHepaticFailure

The fifth subject enrolled in the trial develops severe hepatic failure complicated by encephalopathy one month after starting the study. The study sponsors determined that is an unanticipated problem that must be reported because although the risk of mild liver injury was foreseen, severe liver injury resulting in hepatic failure was unexpected in severity; possibly related to participation in the research; and serious.

AEHepaticFailurecomplication

The fifth subject enrolled in the trial develops severe hepatic failure complicated by encephalopathy one month after starting the study. The study sponsors determined that is an unanticipated problem that must be reported because although the risk of mild liver injury was foreseen, severe liver injury resulting in hepatic failure was unexpected in severity; possibly related to participation in the research; and serious.

AEModeratehives

Moderate hives

Breast Cancer Trial

Breast Cancer clinical trial example

ClinicalTrialSubject5

Clinical Trial subject number 5. Acute Hepatic Failure.

Device - Infuser that exploded

Device - Infuser that exploded

Example patient SLP

Patient enrolled in ACME study, taking Study Medication WBY 10 mg orally daily every morning for moderate asthma

GIBleed

Gastrointestinal (GI) bleed

Janet Blood Pressure Observation

Janet Blood Pressure Observation

Janet Patient

Patient Janet, 64-year old woman on clinical trial

Janet Tylenol PM med

Self reported Janet Tylenol PM med

Janet allergy med

Self reported Janet allergy med

Janet pill for water retention med not known

Self reported Janet pill for water retention med not known

Janet weight Observation

Janet weight observation

Medication Administration for bresentrik

Study medication info Medication Administration for bresentrik

Medication Administration of Med0301

Medication administration example

Medication Request for bresentrik

Study medication info Medication Request for bresentrik

Medication Request for discontinued clinical trial medication 0301

Study medication info Medication Request for clinical trial medication 0301 - discontinued

Medication Request for discontinued clinical trial medication ABC

Study medication info Medication Request for clinical trial medication ABC - discontinued

Medication is bresentrik

Study medication, bresentrik

Patient MOUMIC

Patient MOUMIC on Research Study DISNEY

Problem

Patient reported AE problem

Serious Adverse Event

SAE Patient SCHJO on Research Study XYZ, Study ID XYZ-123, Subject number XYZ-123-002.

clinical-trial-acme-procedure

Clinical trial ACME protocol-prescribed procedure of a Lung CT Scan, with contrast dye

clinical-trial-acme-subject

Clinical trial ACME research subject

clinical-trial-example-compass

Alliance COMPASS Protocol A011801

clinical-trial-example-subject

Alliance COMPASS trial research subject

clinical-trial-example-subject1

Alliance COMPASS trial research subject

medication-administration-contrast-dye

Example medication administration for contrast dye

medication-administration-forhives

Example medication administration for hives

medication-administration-kadcyla

Example showing clinical trial medication administration Kadcyla

medication-administration-kadcyla-reduced

Example reduced dose of clinical trial medication administration Kadcyla

medication-administration-kadcyla1

Example showing clinical trial medication administration Kadcyla

medication-administration-tucatinib

Example showing clinical trial medication administration Tucatinib

medication-administration-tucatinib-reduced

Example reduced does of clinical trial medication administration Tucatinib

medication-administration-tylenol

Example of Tylenol

medication-contrast-dye

Example contrast dye medication

medication-forhives

Example medication for hives

medication-request-example-kadcyla

Example showing clinical trial medication Kadcyla

medication-request-example-kadcyla1

Example showing clinical trial medication Kadcyla

medication-request-example-tucatinib

Example showing clinical trial medication Tucatinib

medication-request-example-zofran

Example for medication Zofran

medication-tylenol

Example medication for Tylenol

patient-example-kaitlyn-b

Compass Trial example patient Kaitlyn

patient-example-kaitlyn-b1

Compass Trial example patient Kaitlynn B1

practitioner-oncology-nurse-jane

Example RN practitioner

practitioner-owen-oncologist

Example Oncologist

procedure-upper-endoscopy

Example Procedure Upper Endoscopy

research-study-DISNEY

Research Study DISNEY

research-study-XYZ

Research Study XYZ

research-study-acme

Research Study ACME

resstudy-medication-WBY

Example clinical trial medication WBY

study-medication-ABC

Example study medication ABC

study-medication-MMD

Example study medication MMD

study-medication-administration-ABC

Example for clinical trial medication ABC

study-medication-administration-MMD

Example for clinical trial medication MMD

study-medication-administration-WBY

Example for clinical trial medication WBY